Monoclonal Antibody Therapy in Parkinson's Disease - The End?

N Engl J Med. 2022 Aug 4;387(5):466-467. doi: 10.1056/NEJMe2207681.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • Humans
  • Immunotherapy
  • Parkinson Disease* / drug therapy

Substances

  • Antibodies, Monoclonal